Search research articles
Contact Us
Filters
Showing results (791-800 of 796) with videos related to
Page
of 80
Sort By:
You have reached the last page of results.
This site can display upto 796 results.
Bioorganic & Medicinal Chemistry Letters
|
January 7, 2020
Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα)
Peter S Dragovich, Pragya Adhikari, Robert A Blake, et al.
Journal of Medicinal Chemistry
|
July 12, 2021
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer
Jun Liang, Jason R Zbieg, Robert A Blake, et al.
Science Translational Medicine
|
April 3, 2024
Pathogenic <i>TNNI1</i> variants disrupt sarcomere contractility resulting in hypo- and hypercontractile muscle disease
Sandra Donkervoort, Martijn van de Locht, Dario Ronchi, et al.
Cancer Cell
|
November 1, 2024
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Diwakar Davar, Robert M Morrison, Amiran K Dzutsev, et al.
Nature Genetics
|
November 13, 2012
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis
David C Whitcomb, Jessica LaRusch, Alyssa M Krasinskas, et al.
The Journal of Trauma and Acute Care Surgery
|
September 16, 2025
Percutaneous pigtail catheter versus chest tube for the treatment of pediatric traumatic hemothorax: An Eastern Association for the Surgery of Trauma multicenter study
Laura F Goodman, Alice M Martino, John Schomberg, et al.
Page
of 80
Search research articles
Search
Showing results (791-800 of 796) with videos related to
Sort By:
Page
of 80
You have reached the last page of results.
This site can display upto 796 results.
Bioorganic & Medicinal Chemistry Letters
|
January 7, 2020
Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα)
Peter S Dragovich, Pragya Adhikari, Robert A Blake, et al.
Journal of Medicinal Chemistry
|
July 12, 2021
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer
Jun Liang, Jason R Zbieg, Robert A Blake, et al.
Science Translational Medicine
|
April 3, 2024
Pathogenic <i>TNNI1</i> variants disrupt sarcomere contractility resulting in hypo- and hypercontractile muscle disease
Sandra Donkervoort, Martijn van de Locht, Dario Ronchi, et al.
Cancer Cell
|
November 1, 2024
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Diwakar Davar, Robert M Morrison, Amiran K Dzutsev, et al.
Nature Genetics
|
November 13, 2012
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis
David C Whitcomb, Jessica LaRusch, Alyssa M Krasinskas, et al.
The Journal of Trauma and Acute Care Surgery
|
September 16, 2025
Percutaneous pigtail catheter versus chest tube for the treatment of pediatric traumatic hemothorax: An Eastern Association for the Surgery of Trauma multicenter study
Laura F Goodman, Alice M Martino, John Schomberg, et al.
Page
of 80